Centricity Vision Appoints Jim Mazzo to its Board of Directors

By
CARLSBAD, Calif.—Centricity Vision, a global ophthalmic technology company, announced that Jim Mazzo has been appointed to the company’s board of directors. Mazzo is one of the ophthalmic industry’s best known and most well respected business leaders with over 40 years of experience. His global reputation for building and running world-class organizations is based on 22 years leading Allergan’s North American and European eyecare organizations; seven years as Chairman, president and CEO of Advanced Medical Optics (AMO); four years as executive vice president of Abbott’s global ophthalmology business; three years as executive chair and CEO of AcuFocus and nearly four years as global president of ophthalmic devices for Carl Zeiss Meditec.

“Jim will provide valuable strategic guidance and insight as we expand our vision care pipeline. We are grateful for his support and confidence in our team, technology and company vision,” said Rob Thornhill, president and CEO of Centricity Vision. “I am excited and honored to have Jim join our board as we execute our mission of creating a suite of next-generation ophthalmic capsular management devices.”

Centricity Vision is the developer of the U.S. and internationally approved Zepto Precision Cataract Surgery Platform, which enables consistent, visual axis-centered, high-quality anterior capsulotomies during cataract surgery, according to a statement from the company.